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There exists no separate coordination unit for 
diabetes in Cambodia. A very limited number of 
organizations work in diabetes, these include: 
Médecins Sans Frontières, Belgium (MSF) and 
the charity hospital Centre of Hope: two inter-
national organizations providing free treatment 
for diabetes and other chronic diseases; and 
Actors involved in  
Diabetes care
two local organizations working to empower 
patients: the Cambodian Diabetes Association 
(CDA), which brings together doctors and 
patients within the same organization, and the 
Patient Information Centre – MoPoTsyO – with 
patients educating their peer-patients.
Despite the increasing burden of chronic diseases 
in the world and the fact that they have now 
become diseases of poor people in most settings, 
the needs of these patients have remained largely 
unmet.
 
In Cambodia, recent surveys revealed a diabetes 
prevalence of 11% in a semi-urban community 
and an unexpectedly high prevalence of 5% in 
a relatively poor, traditional, rural community. 
An estimated 255. 000 people live with diabetes 
today in Cambodia. 
Before I knew I had diabetes I weighed about 80kg. When I became ill my weight went down to 
57kg. Everyone thought I had AIDS because I became very skinny. My friend who works as a 
HIV/AIDS counsellor at Takeo clinic suggested that I should go for an HIV test. I went to a private 
clinic in Takeo for diagnosis but I did not have HIV/AIDS.
Diabetic patient, Takeo
Untreated diabetes is associated with uncontrolled 
hyperglycemia that gives rise to the risk of micro-
vascular damage (retinopathy, nephropathy and 
neuropathy) and macrovascular complications 
(ischemic heart disease, stroke and peripheral 
vascular disease), diminished quality of life and 
reduced life expectancy. There is now ample 
evidence that good glycemic control reduces 
the risk of diabetes complications.
Chronic Diseases and 
Diabetes in Cambodia
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MSF & Chronic Diseases 
Clinics in Cambodia
In 2002 Médecins Sans Frontières (MSF), in 
collaboration with the Ministry of Health of 
Cambodia, initiated a program to provide care 
for diabetes and hypertension in three public 
hospital clinics in rural locations (Siem Reap in 
2002, Sotnikum in 2003, and Takeo in 2003). 
The similarities between the management of 
these two chronic conditions and HIV/AIDS 
led MSF to set up a Chronic Disease Clinic off ering 
integrated care for  HIV/AIDS patients and those 
suff ering from diabetes and/or hypertension. This 
novel experience has demonstrated the feasibility 
of integrating care for chronic diseases with HIV/
AIDS and has attracted the interest of various 
actors including international medical journals. 
Context
In Cambodia medical care for diseases such as 
diabetes, arterial hypertension or epilepsy was not 
generally included in the post-war reconstruction 
of the health care system over the last 15 years. 
Most diabetics receive only a limited amount of 
medication at the outpatient department of a 
referral hospital or when they arrive with severe 
hyperglycaemia at the emergency ward; they are 
rarely referred to long-term care once they are 
discharged. Some drugs to treat hypertension 
are available at hospitals and health centres but 
these are usually provided only for two weeks.  
Siem Reap and Takeo are both predominantly 
rural provinces (although the urban population 
of Siem Reap town is increasing rapidly due to 
the growing tourism industry around the Angkor-
Wat temple complex).  Both locations were 
selected for this programme because they are 
large provincial centres with referral-hospital 
level capacity to expand activities. 
Rationale for the chronic 
diseases clinics
The rationale to combine care of HIV/AIDS, 
diabetes and hypertension was based on three 
assumptions.
First, the availability of antiretroviral treatment 
in developing countries is transforming HIV/AIDS 
into a chronic disease, as has been the experience 
in the West. It was anticipated that, in this resource-
poor context, effi  ciency gains could be attained 
through the establishment of a multidisciplinary 
chronic-disease care team that would use a 
common approach to respond to the specific 
needs of chronic diseases patients. This was 
especially true for strategies providing continuity 
of care, long-term adherence support, and social 
support.  
For three years I bought medicine from a private clinic to treat my disease. Then I had no more money 
to buy medicine … I spent about US$30 per week on medication. I sold my productive land for 
US$1,800 to treat my disease…
Diabetic patient, Takeo
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Second, in Cambodian society, stigma towards 
Persons Living with HIV/AIDS (PLHAs) presents a 
barrier to care. By providing care for PLHAs along 
with patients with other chronic diseases, within 
the same facility and by the same team, it was 
hoped that facility-related stigma could be 
reduced as compared to when PLHAs were treated 
in a separate and specifi c health service. 
Third, it was considered important that the health 
care delivery model should refl ect the epidemio-
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I became poor because of my disease. I sold everything to take care of myself. Now I don’t have 
any more money. My children support me, but when they didn’t have money to help me I stopped 
buying the medicine because I don’t want to borrow money anymore from other people. I don’t 
want to have debt.
Diabetic patient
logical reality: Diabetes was given a specific 
priority since it was seen by many health workers 
as a common problem and was recognized to 
contribute an increasing share of the disease 
burden in the country. The provision of systematic 
and continuous care for chronic diseases was 
encouraged by representatives of both the 
Ministry of Health and local World Health 
Organization representatives who were involved 
in the final design of this pilot health care 
delivery model. 
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We initiated the diabetic treatment program  in 
March 2002 in Siem Reap province (population 
700,000) and in March 2003 in Takeo province 
(population 800,000). The programs consisted of 
outpatient clinics at the public referral hospital 
level and operated similarly in both locations. 
We provided integrated, patient-centered care, 
similar to that off ered to HIV-positive patients, 
for those with diabetes. Most patients had been 
previously diagnosed with diabetes, either by 
a local health provider or a laboratory. The clinic 
staff  included general practitioners and nurses 
trained in diabetes care, drug educators, 
adherence counselors, a receptionist and support 
staff  to facilitate patient fl ow. The same health 
personnel also attended patients with other 
chronic conditions (HIV/AIDS, hypertension). 
MSF subsidized care: patients were required to 
pay the initial registration fee (1 USD), a fee for 
diabetic and anti-hypertensive drugs (1.1 USD for 
a 3-month treatment of glibenclamide and 4.5 USD 
for a three-month treatment of metformin) until 
mid-2005, and transportation costs. However, 
from mid-2005 onward, all drugs were free of 
MSF Program Description
charge. Transportation costs for patients were 
never covered by the program.
Standardized care and
follow up procedures
Health education and counselling:
Advice on exercise and appropriate diet was given 
to patients on an individual basis. Until 2005 this 
was provided at the end of the consultation by 
the doctor, and after 2005 by a well-trained nurse 
in a separate counseling session and in group 
sessions. The food model were used with focus on 
food groups, and especially meal planning for 
diabetes patients where little has been done by
other actors in the country.
Treatment:
When medical treatment was required an oral 
hypoglycemic agent as mono therapy such as 
metformin was used if  body mass index 
© André François
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(BMI)≥23 kg/m2 , or glibenclamide if BMI<23kg/m2 
and/or if there were contraindications to met-
formin.  A second oral agent was added for 
patients failing to reach glucose control with 
mono therapy.
Insulin therapy was reserved for patients with 
Type I diabetes, pregnancy, or those with 
moderate to severe renal impairment. 
We saw patients after treatment initiation every 
one to two weeks, then monthly and eventually 
every three months once glycaemia was controlled 
(RBG <200mg/dl). At each follow up visit, we 
measured random blood glucose level, weight, 
blood pressure, and performed clinical screening 
for complications. Blood pressure was measured 
seated after fi ve minutes rest and involved at least 
two readings on the same day. We checked for 
treatment acceptance, tolerance, and adherence 
with open-ended questions. If drug intake was 
irregular, counselors provided adherence advice
and support. A patient was defined as “lost to 
Diabetes is not the same as HIV/AIDS because there is no information about the disease and there is 
no support available for diabetes whereas for HIV/AIDS there is plenty of information and they receive 
a lot of support
Diabetic patient
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follow up" (LTFU) if their last contact with the clinic 
was more than three months before and they 
were not known to be dead or transferred out. 
Until 2007, due to lack of resources, clinicians used 
RBG, generally done in the morning to estimate 
overall glycemic control and used the cut-off 
value of 180 mg/dl (10mmol/l) as an acceptable 
level. Systematic measurement of hemoglobin A1c 
(HbA1c) for monitoring glucose control at the 
individual level started in 2007. 
Data collection & monitoring 
and evaluation tools
We recorded clinical information on standardized 
clinical fi les specifi cally designed for diabetic care. 
Trained personnel extracted clinical, treatment, 
and laboratory data from individual patient 
records daily and entered them into an electronic 
medical record software program developed 
locally, specifi cally for chronic diseases. 
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MSF Program Outcomes
A total of 4404 diabetic patients were registered 
in the two clinics (Siem Reap and Takeo) over 
the  fi ve year period. Patients not lost to follow-up 
underwent an average of 10 consultations per 
year. Only 4% of patients were prescribed insulin 
at their last consultation and 41% of patients on 
oral treatment were prescribed two anti-diabetic 
drugs at their last consultation. . 
Number of diabetic patients 
registered 
 (March 2002 to June 2008) 4404
Diabetes Type 1
Diabetes Type 2 
54 (1%)
4350 (99%)
Median age in years (IQR) 53 (46-60)
Women 2905 (66%)
Prevalence of high blood 
pressure on admission
Systolic blood pressure ≥140 mmHg
Diastolic blood pressure ≥ 90 mmHg
40%
34%
Prevalence of overweight 
on admission
BMI ≥23 kg/m2
BMI ≥ 27.5 kg/m2
56%
16%
Patients diagnosed
with diabetes
N=4404
Died
N=24
Transferred out
N=135
Lost to follow-up
N=1508
Lost to follow up ≤1 year
N=869
Attended only 1
consultation
N=249
Lost to follow-up >1 year
N=390
Active on treatment
N=2737
 Clinical outcomes of diabetic patients enrolled in the program:
Clinical outcomes of diabetic 
patients enrolled in the program:
Glucose, blood pressure, and 
weight control 
Proportion of diabetic patients reaching the recommended 
optimal targets
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Treatment duration in months
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0% 
M6 M12 M24 M36 M48 M60
HbA 1c<= 7.0%
RBG < 145mg/dl
BMI < 27.5 KG/m2
SBP < 140mmHg
DBP < 90mmHg
17.6%
33.5%
39.8%
58.9%
35.5% 35.2%
21.1%
37.8%
62.6% 32,4%
78,8%
33,3%
63,6%
24,0%
25,6%
33,9%
37,1%
25,6%
35.4% 35,1%
17,7%
24.3%
22.4%21.1%
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Note:
Approximately 300 patients with diabetes were enrolled and treated in Sotnikum Chronic Disease 
Clinic. The analyses in this chapter describe the outcomes of Siem Reap and Takeo clinics only, 
as Sotnikum clinic was handed over to MoH in 2006.
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Except for BMI, other parameters showed an 
initial drop during the fi rst six months of treat-
ment, which was maintained over the fi ve-year 
period. 
Risk factors for loss to follow-up 
Factors signifi cantly associated with loss to follow-
up were male gender, age older than 60 years, 
living outside the province, normal BMI (<23kg/m2) 
on admission, high random blood glucose 
(≥180mg/dl) on last consultation, and coming 
late for the last consultation.
I live in Phnom Penh but I come to Takeo to get treatment at MSF. I am too old to come by myself 
and it is too far, so my children have to take me here every month. Sometimes I ask other people 
to take e here but I have to pay for gasoline. I depend on my children and relatives to take me here 
so that I can get my medicine every month
Diabetic patient, Phnom Penh
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The treatment outcomes of this large cohort of diabetic patients receiving standardized care in 
the chronic disease clinics are encouraging even though the majority did not reach the recommended 
targets for optimal diabetes control. In light of the evidence that any decrease in glycosylated 
hemoglobin level is associated with a decreased risk for cardiovascular disease and mortality in 
persons with Type 2 diabetes, patients with improved glycaemia likely gained some clinical benefi t 
even if they did not reach the target.
 The integration of a diabetic care with HIV care allowed for a rationalization of resources but 
did not cover all needs of diabetic patients 
  In Cambodia HbA1c is only available in two locations and is at least eight times more 
expensive than CD4 count
  Without free care off ered by MSF, laboratory and drug costs if assumed by patients could 
act as barriers to meeting treatment goals
© André François
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Challenges
I now get treatment at Takeo clinic but I do not have any social support from any NGO. I still have 
to pay 6.000 Riel [US$1.50] for medication every month. But it is not the same with PLHA they get 
rice every month and don’t have to pay anything for medicine. They even receive money for 
transportation to the clinic. But for people with diabetes no one helps us. So I think if I had AIDS 
it would be better. My husband thought I was crazy to say this but this is true
Diabetic patient, Phnom Penh
I do not receive any social support from any organization. We diabetic patients tend to say that 
HIV/AIDS patients are lucky because they have an NGO helping them but for us we don’t have any 
support; instead they charge us for medicine. Honestly, I wish I had AIDS more than diabetes.  
Diabetic patient, Takeo
The reasons for less than optimal glucose control 
results are multi-factorial and include poor 
adherence to taking medication, the use of 
random blood glucose instead of HbA1c for 
patient monitoring, poor weight control, and lack 
of therapy intensification, ie insulin, (<4% of 
patients on insulin). 
The very low number of patients on insulin refl ects 
the programmatic challenges of delivering insulin 
in a resource-constrained setting. Barriers to 
the use of insulin in our setting include the cost, 
problems with cold chain storage, cost and diffi  -
culties in learning how to use glucose monitoring 
equipment, and less than ideal education and 
support for patient self management. 
Weight control results in our diabetic cohort were 
poor and could be, in part, due to insuffi  cient and 
inadequate patient education. Lifestyle changes 
imply both environmental and behavioral 
changes. There could be a cultural reluctance to 
lose weight, since there is no dietary advice and 
no promotion of physical exercise at the popu-
lation level in the country. This is compounded 
by the fact that in Cambodia, the rice-dominated 
diet is carbohydrate-rich and most of the popu-
lation living in urban and semi-urban areas tend 
to adopt a sedentary lifestyle. 
The high Last to follow-up rate observed among 
this cohort of diabetic patients contrasts with the 
low Last to follow-up rate documented among 
HIV/AIDS patients treated in the same chronic 
disease clinic (3%). One contributing factor could 
be the inequality in care: HIV/AIDS patients 
received free health care, money for transportation, 
food, and social support, while diabetic patients 
did not get any of those benefi ts.  
In Cambodia HbA1c is only available in two 
locations and is at least eight times more 
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Challenges
expensive than a CD4 count, used for monitoring 
HIV patients on ART. Additionally, other eff ective 
measures to reduce cardiovascular risks such as 
lipid-lowering drugs (statins) were beyond the 
program's fi nancial capacity. 
However, the estimated cost for drug therapy 
based on the local drug prices was rather aff ordable 
 Possible reasons for suboptimal glucose control
 patient poor-adherence
 use of random blood glucose instead of HbA1c for monitoring
 poor weight control & lack of adequate life-style modification advice
 lack of therapy intensification, especially insulin
 Barriers to use of insulin in our setting
 financial cost 
 cold chain requirements 
 purchase and use of glucose monitoring equipment
 patient self-management requiring further education and support
at approximately 48 USD/per year for monotherapy 
(Glibenclamide) and 192 USD/year for bi-therapy 
(Glibenclamide and Metoformin). 
But overall, without free care offered by MSF, 
laboratory and drug costs, if assumed by patients, 
could act as barriers to meeting treatment goals. 
© André François
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 International donors, aid organizations and the scientific community need to urgently 
increase the priority for chronic diseases in resource-constrained settings as their burden of 
illness is substantial and continuing to increase.
 Political willingness and technical support are not enough to kick-start functional diabetes 
clinics in Cambodia; adequate funds are urgently needed.
 Key features of the management of chronic diseases in a resource-limited setting like 
Cambodia should include standardized diagnosis and treatment protocols, a multidisciplinary 
team, and free care including drugs. 
 There is an urgent need for constant supply of good quality oral anti-diabetic medicines 
that cover the needs of all public hospitals.
 Insulin therapy is a corner stone for the management of diabetes. Increased access to insulin, 
training of clinicians and inclusion of insulin therapy in the national treatment protocols are 
needed.
 To achieve glycemic control increased access to and use of HbA1c testing is essential, as it 
remains the gold standard for patient monitoring.
 Interventions to improve patient self-empowerment are essential for program success and 
treatment adherence.   
 Complementary actions at the population level to promote lifestyle changes and achieve 
healthy body weight need to be established. 
 Operational research should be promoted as a means of improving the quality of care in 
chronic disease clinics. 
Recommendations
Re
co
m
m
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ns
ARE  URGENTLY NEEDED…
 Funds to be allocated to national non-communicable diseases program (international 
donors, national budget)
 Constant supply of oral anti-diabetic and anti-hypertensive drugs, of good quality and 
adequate quantity
  Access to HbA1c testing and insulin 
 Interventions to improve patient self-empowerment
 Complementary actions at the population level to promote lifestyle changes 
 Operations research 
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